79938 Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 25, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–22438 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; NIDA– 

L conflict SEP. 

Date: November 5, 2024. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sudhirkumar U. 

Yanpallewar, M.D., Scientific Review Officer, 

Scientific Review Branch, National Institute 

on Drug Abuse, NIH, 301 North Stonestreet 

Avenue, MSC 6021, Bethesda, MD 20892, 

(301) 443–4577, sudhirkumar.yanpallewar@

nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Mechanism for Time-Sensitive Drug Abuse 

Research. 

Date: November 12, 2024. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sudhirkumar U. 

Yanpallewar, M.D., Scientific Review Officer, 

Scientific Review Branch, National Institute 

on Drug Abuse, NIH, 301 North Stonestreet 

Avenue, MSC 6021, Bethesda, MD 20892, 

(301) 443–4577, sudhirkumar.yanpallewar@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: September 26, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22526 Filed 9–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting for the 

Interdepartmental Serious Mental 

Illness Coordinating Committee 

(ISMICC) 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The Secretary of Health and 

Human Services announces a meeting of 

the Interdepartmental Serious Mental 

Illness Coordinating Committee 

(ISMICC). 

The meeting will provide information 

on federal efforts related to serious 

mental illness (SMI) and serious 

emotional disturbance (SED); and 

Report Outs from Focus Area 1—Data 

and Evaluation; Focus Area 2—Access 

and Engagement; Focus Area 3— 

Treatment and Recovery; Focus Area 

4—Criminal Justice, and Focus Area 5— 

Finance; and updates on SAMHSA’s 

initiatives. 

DATES: October 29, 2024, 9:00 a.m. to 

4:00 p.m. (EDT)/Open. 

ADDRESSES: The meeting is open to the 

public and can be accessed virtually 

only by accessing: https://

www.zoomgov.com/j/1604912525?pwd=

XrfbvgFJM7BnfEq1xJIHRgiIsCKaEF.1 or 

by dialing 646–828–7666, webinar ID: 

160 491 2525, passcode: 689916. 

Agenda with call-in information will be 

posted on the SAMHSA website prior to 

the meeting at https://www.samhsa.gov/ 

about-us/advisory-councils/meetings. 

FOR FURTHER INFORMATION CONTACT: 

Pamela Foote, ISMICC Designated 

Federal Officer, SAMHSA, 5600 Fishers 

Lane, Rockville, MD 20857; telephone: 

240–276–1279; email: pamela.foote@

samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background and Authority 

The ISMICC was established on 

March 15, 2017, in accordance with 

section 6031 of the 21st Century Cures 

Act, and the Federal Advisory 

Committee Act, 5 U.S.C. App., as 

amended, to report to the Secretary, 

Congress, and any other relevant federal 

department or agency on advances in 

SMI and SED, research related to the 

prevention of, diagnosis of, intervention 

in, and treatment and recovery of SMIs, 

SEDs, and advances in access to services 

and supports for adults with SMI or 

children with SED. In addition, the 

ISMICC will evaluate the effect federal 

programs related to SMI and SED have 

on public health, including public 

health outcomes such as: (A) rates of 

suicide, suicide attempts, incidence and 

prevalence of SMIs, SEDs, and 

substance use disorders, overdose, 

overdose deaths, emergency 

hospitalizations, emergency room 

boarding, preventable emergency room 

visits, interaction with the criminal 

justice system, homelessness, and 

unemployment; (B) increased rates of 

employment and enrollment in 

educational and vocational programs; 

(C) quality of mental and substance use 

disorders treatment services; or (D) any 

other criteria determined by the 

Secretary. Finally, the ISMICC will 

make specific recommendations for 

actions that agencies can take to better 

coordinate the administration of mental 

health services for adults with SMI or 

children with SED. Not later than one 

(1) year after the date of enactment of 

the 21st Century Cures Act, and five (5) 

years after such date of enactment, the 

ISMICC shall submit a report to 

Congress and any other relevant federal 

department or agency. 

II. Membership 

This ISMICC consists of federal 

members listed below or their 

designees, and non-federal public 

members. 

Federal Membership: Members 

include, The Secretary of Health and 

Human Services; The Assistant 

Secretary for Mental Health and 

Substance Use; The Attorney General; 

The Secretary of the Department of 

Veterans Affairs; The Secretary of the 

Department of Defense; The Secretary of 

the Department of Housing and Urban 


khammond on DSKJM1Z7X2PROD with NOTICES